Actinium Pharmaceuticals
ATNM
ATNM
59 hedge funds and large institutions have $7.36M invested in Actinium Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
Holders
59
Holding in Top 10
–
Calls
$219K
Puts
–
Top Buyers
| 1 | +$170K | |
| 2 | +$149K | |
| 3 | +$103K | |
| 4 |
Squarepoint
New York
|
+$95.9K |
| 5 |
B
Bailard
Foster City,
California
|
+$84.4K |
Top Sellers
| 1 | -$185K | |
| 2 | -$42.1K | |
| 3 | -$35.9K | |
| 4 |
GS
Gagnon Securities
New York
|
-$35.7K |
| 5 |
Millennium Management
New York
|
-$33.7K |
